Piramal Pharma On ADC-Making Edge, BIOSECURE Act, $2Bn-Mark Strategy

 
• By Vibha Ravi
  
Nandini Piramal, Chairperson, Piramal Pharma
Interview with Nandini Piramal, Chairperson, Piramal Pharma
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Financing